Acquisition of Start-Up PressCise AB


Wernli AG expands innovations in compression therapy with acquisition of the Start-Up PressCise


In a strategic move to enhance our product portfolio and lead the way in compression therapy innovation, we proudly announce the acquisition of a cutting-edge compression start-up, PressCise AB. This strategic collaboration aims to introduce an innovative compression system that promises to revolutionize the industry.

PressCise AB, known for its research-driven approach to compression therapy, has developed the Lundatex compression system and stockings that offer improved comfort, enhanced efficacy, and user-friendly design. We are now in the process of integrating this innovative technology into our manufacturing processes, gearing up for the highly anticipated product launch in the second quarter of 2024.

We are thrilled to integrate innovative Lundatex compression technology into our product offerings. This strategic acquisition reinforces our dedication to providing high-quality, state-of-the-art solutions addressing the evolving needs of healthcare professionals and patients alike.

For further information about the Lundatex products and the Start-Up PressCise, please visit PressCise AB | Lundatex compression | Sweden